Molecular mechanisms of L-DOPA-induced dyskinesia, Nature Reviews Neuroscience, vol.68, issue.9, pp.665-677, 2008. ,
DOI : 10.1038/nrn2471
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia, Trends in Neurosciences, vol.30, issue.5, pp.236-243, 2007. ,
DOI : 10.1016/j.tins.2007.03.005
Molecular mechanisms underlying levodopa-induced dyskinesia, Movement Disorders, vol.3, issue.S3, pp.570-579, 2008. ,
DOI : 10.1002/mds.22019
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia, Journal of Neurochemistry, vol.25, issue.2, pp.381-392, 2006. ,
DOI : 10.1016/0166-2236(90)90112-N
Is the Ras-MAPK signalling pathway necessary for long-term memory formation?, Trends in Neurosciences, vol.22, issue.1, pp.38-44, 1999. ,
DOI : 10.1016/S0166-2236(98)01306-X
Cellular Mechanisms of Striatum-Dependent Behavioral Plasticity and Drug Addiction, Current Molecular Medicine, vol.2, issue.7, pp.649-665, 2002. ,
DOI : 10.2174/1566524023362005
Targeting Ras/ERK signaling in the striatum: will it help?, Molecular Psychiatry, vol.8, issue.4, pp.366-368, 2003. ,
DOI : 10.1038/sj.mp.4001291
ERK2: a logical AND gate critical for drug-induced plasticity?, Current Opinion in Pharmacology, vol.7, issue.1, pp.77-85, 2007. ,
DOI : 10.1016/j.coph.2006.08.012
URL : https://hal.archives-ouvertes.fr/inserm-00128883
Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA???Induced Dyskinesia and the Role of Dopamine D1 Receptors, Biological Psychiatry, vol.62, issue.7, pp.800-810, 2007. ,
DOI : 10.1016/j.biopsych.2006.11.032
Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia, Journal of Neuroscience, vol.27, issue.26, pp.6995-7005, 2007. ,
DOI : 10.1523/JNEUROSCI.0852-07.2007
ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice, Biological Psychiatry, vol.59, issue.1, pp.64-74, 2006. ,
DOI : 10.1016/j.biopsych.2005.05.044
The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease, Journal of Neuroscience, vol.28, issue.17, pp.4311-4316, 2008. ,
DOI : 10.1523/JNEUROSCI.4720-07.2008
The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory, Journal of Neurochemistry, vol.16, issue.1, pp.1-10, 2001. ,
DOI : 10.1046/j.1471-4159.2001.00054.x
Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review, Genes, Brain and Behavior, vol.110, issue.2, pp.61-72, 2006. ,
DOI : 10.1111/j.1601-183X.2006.00230.x
The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells, The International Journal of Biochemistry & Cell Biology, vol.40, issue.12, pp.2707-2719, 2008. ,
DOI : 10.1016/j.biocel.2008.04.009
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence, FEBS Journal, vol.5, issue.1, pp.2-21, 2010. ,
DOI : 10.1111/j.1742-4658.2009.07366.x
Pathological roles of MAPK signaling pathways in human diseases, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1802, issue.4, pp.396-405, 2010. ,
DOI : 10.1016/j.bbadis.2009.12.009
URL : https://hal.archives-ouvertes.fr/hal-00566733
Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) Controls Activation of Extracellular Signal-Regulated Kinase (ERK) Signaling in the Striatum and Long-Term Behavioral Responses to Cocaine, Biological Psychiatry, vol.66, issue.8, pp.758-768, 2009. ,
DOI : 10.1016/j.biopsych.2009.03.014
A role for the Ras signalling pathway in synaptic transmission and long-term memory, Nature, vol.390, pp.281-286, 1997. ,
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia, Experimental Neurology, vol.194, issue.1, pp.66-75, 2005. ,
DOI : 10.1016/j.expneurol.2005.02.002
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA???Induced Dyskinesia and Histone Activation, Biological Psychiatry, vol.66, issue.6, pp.603-613, 2009. ,
DOI : 10.1016/j.biopsych.2009.04.025
A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function, Neurobiology of Disease, vol.16, issue.1, pp.110-123, 2004. ,
DOI : 10.1016/j.nbd.2004.01.007
Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties, J Neurosci, vol.20, pp.8701-8709, 2000. ,
l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice, Journal of Neurochemistry, vol.20, issue.3, pp.621-633, 2009. ,
DOI : 10.1111/j.1471-4159.2008.05831.x
Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia, Neurobiology of Disease, vol.17, issue.2, pp.219-236, 2004. ,
DOI : 10.1016/j.nbd.2004.07.005
Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia, Journal of Neurochemistry, vol.62, issue.4, pp.1395-1409, 2007. ,
DOI : 10.1016/0006-8993(86)90893-0
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy, Proceedings of the National Academy of Sciences, vol.106, issue.8, pp.2892-2896, 2009. ,
DOI : 10.1073/pnas.0812822106
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters, Nature Biotechnology, vol.6, issue.1, pp.108-116, 2005. ,
DOI : 10.1038/nm871
Lentiviral Vectors to Study the Differential Function of ERK1 and ERK2 MAP Kinases, Methods Mol Biol, vol.661, pp.205-220, 2010. ,
DOI : 10.1007/978-1-60761-795-2_12
The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1, Neuron, vol.40, issue.4, pp.775-784, 2003. ,
DOI : 10.1016/S0896-6273(03)00645-7
URL : https://hal.archives-ouvertes.fr/inserm-00484801
Characterization and Properties of Dominant-negative Mutants of the Ras-specific Guanine Nucleotide Exchange Factor CDC25Mm, Journal of Biological Chemistry, vol.274, issue.51, pp.36656-36662, 1999. ,
DOI : 10.1074/jbc.274.51.36656
ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially, Journal of Biology, vol.5, issue.5, pp.14-15, 2006. ,
DOI : 10.1016/0092-8674(91)90503-Q
URL : http://doi.org/10.1186/jbiol38
Treatment of levodopa-induced motor complications, Movement Disorders, vol.121, issue.S3, pp.599-612, 2008. ,
DOI : 10.1002/mds.22052
l-DOPA-induced dyskinesia in Parkinson's disease: a drug discovery perspective, Drug Discovery Today, vol.15, issue.19-20, pp.19-20867, 2010. ,
DOI : 10.1016/j.drudis.2010.08.014
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors, Proceedings of the National Academy of Sciences, vol.107, issue.33, pp.14845-14850, 2010. ,
DOI : 10.1073/pnas.1009874107
Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease, Science Translational Medicine, vol.2, issue.28, pp.28-28, 2010. ,
DOI : 10.1126/scitranslmed.3000664
Maladaptive striatal plasticity in l-DOPA-induced dyskinesia, Prog Brain Res, vol.183, pp.209-233, 2010. ,
DOI : 10.1016/S0079-6123(10)83011-0
Future of cell and gene therapies for Parkinson's disease, Annals of Neurology, vol.19, issue.S2, pp.122-138, 2008. ,
DOI : 10.1002/ana.21473
Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders, Current Gene Therapy, vol.8, issue.6, pp.461-473, 2008. ,
DOI : 10.2174/156652308786847996
Gene therapy for neurodegenerative diseases based on lentiviral vectors, Prog Brain Res, vol.175, pp.187-200, 2009. ,
DOI : 10.1016/S0079-6123(09)17513-1
Trophic factors therapy in Parkinson's disease, Prog Brain Res, vol.175, pp.201-216, 2009. ,
DOI : 10.1016/S0079-6123(09)17514-3
cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum, J Neurosci, vol.21, pp.9930-9943, 2001. ,
Striatal Overexpression of ??JunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease, Biological Psychiatry, vol.66, issue.6, pp.554-561, 2009. ,
DOI : 10.1016/j.biopsych.2009.04.005
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nature Medicine, vol.9, issue.6, pp.762-767, 2003. ,
DOI : 10.1038/nm875
RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease, Journal of Neuroscience, vol.27, issue.52, pp.14338-14348, 2007. ,
DOI : 10.1523/JNEUROSCI.4223-07.2007
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey, Brain, vol.124, issue.3, pp.546-557, 2001. ,
DOI : 10.1093/brain/124.3.546
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning, European Journal of Neuroscience, vol.49, issue.1, pp.283-287, 2005. ,
DOI : 10.1111/j.1460-9568.2005.04196.x